Nuvectis Pharma News

Wall Street Analysts See a 229.34% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This High?

Yahoo FinanceMay 24 09:55 ET

Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference

Fort Lee, NJ, May 16, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ:NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative

GlobeNewswireMay 16 08:30 ET

Nuvectis Pharma(NVCT.US) 10% Shareholder Buys US$13,075.6 in Common Stock

$Nuvectis Pharma(NVCT.US)$ 10% Shareholder BENTSUR RON purchased 1,940 shares of common stock on May 14, 2024 at an average price of $6.74 for a total value of $13,075.6.Source: Announcement What is s

moomoo NewsMay 15 09:58 ET

Nuvectis Pharma(NVCT.US) 10% Shareholder Buys US$12,800 in Common Stock

$Nuvectis Pharma(NVCT.US)$ 10% Shareholder BENTSUR RON purchased 2,000 shares of common stock on May 10, 2024 at an average price of $6.4 for a total value of $12,800.Source: Announcement What is stat

moomoo NewsMay 13 09:32 ET

Nuvectis Pharma(NVCT.US) Officer Buys US$3,145 in Common Stock

$Nuvectis Pharma(NVCT.US)$ Officer Poradosu Enrique purchased 500 shares of common stock on May 10, 2024 at an average price of $6.29 for a total value of $3,145.Source: Announcement What is statement

moomoo NewsMay 13 09:32 ET

Nuvectis Pharma(NVCT.US) Officer Buys US$7,034.16 in Common Stock

$Nuvectis Pharma(NVCT.US)$ Officer Shemesh Shay purchased 1,113 shares of common stock on May 10, 2024 at an average price of $6.32 for a total value of $7,034.16.Source: Announcement What is statemen

moomoo NewsMay 13 09:27 ET

Nuvectis Pharma Price Target Maintained With a $21.00/Share by HC Wainwright & Co.

Nuvectis Pharma Price Target Maintained With a $21.00/Share by HC Wainwright & Co.

Dow JonesMay 8 15:13 ET

Express News | HC Wainwright & Co. Reiterates Buy on Nuvectis Pharma, Maintains $21 Price Target

BenzingaMay 8 15:03 ET

Nuvectis Pharma Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 172.73% HC Wainwright & Co. → $21 Reiterates Buy → Buy 09/15/2023 172.73% HC Wainwright & Co. →

BenzingaMay 8 15:02 ET

Strong Buy Rating for Nuvectis Pharma on Robust Financials and Promising Oncology Drug Trials

TipRanksMay 8 10:05 ET

Nuvectis Pharma Inc Reports Q1 2024 Financial Outcomes

Yahoo FinanceMay 7 21:06 ET

Nuvectis Pharma | 10-Q: Quarterly report

SEC announcementMay 7 16:38 ET · Announcements

Express News | Nuvectis Pharma Q1 EPS $(0.25) Beats $(0.40) Estimate

BenzingaMay 7 08:11 ET

Nuvectis Pharma: Runway Into 2nd Half of 2025 >NVCT

Nuvectis Pharma: Runway Into 2nd Half of 2025 >NVCT

Dow JonesMay 7 08:07 ET

Nuvectis Pharma 1Q Loss/Shr 25c >NVCT

Nuvectis Pharma 1Q Loss/Shr 25c >NVCT

Dow JonesMay 7 08:05 ET

Express News | Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights

ReutersMay 7 08:00 ET

Express News | Nuvectis Pharma Q1 Operating Income USD -4.396 Million

ReutersMay 7 08:00 ET

Express News | Nuvectis Pharma Q1 Net Income USD -4.171 Million

ReutersMay 7 08:00 ET

Press Release: Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights

Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights -- Encouraging preliminary data announced from the NXP800 Phase 1b study in platinum resistant, ARI

Dow JonesMay 7 08:00 ET

Analysts Offer Insights on Healthcare Companies: Nuvectis Pharma (NVCT) and Invivyd (IVVD)

TipRanksApr 8 12:10 ET